Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT06556745

Pharmacokinetics of Butyrate Tablet BKR-017

Sponsor: BioKier Inc.

View on ClinicalTrials.gov

Summary

The purpose of this study is to evaluate the pharmacokinetic profile and systemic exposure of BKR-017 in individuals on statin therapy after a single dose and at steady state after seven days repeated twice daily dosing.

Official title: A Phase 1 Study of Safety and Pharmacokinetics of BKR-017 in Individuals on Statin Therapy

Key Details

Gender

All

Age Range

18 Years - 70 Years

Study Type

OBSERVATIONAL

Enrollment

9

Start Date

2025-07-16

Completion Date

2026-06-04

Last Updated

2026-06-09

Healthy Volunteers

Not specified

Interventions

DRUG

BKR-017

BKR-017 is an oral tablet formulation designed to target delivery of sodium butyrate to the colon via colon-targeting technology.

Locations (1)

Pennington Biomedical Research Center

Baton Rouge, Louisiana, United States